Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
XTLB XTL shares drop 487 as quarterly loss widens revenue growth remains elusive Is Privia PRVA stock a good candidate for diversification Q4 2025 EPS Tops Views Blink BLNK Stock Decreases Stake 435 20260418 Kevin Warshs Potential Fed Shift Could Reshape Wall Streets Market Plumbing Ashok Leyland Q4 FY26 Net Profit Rises 14 to Rs 1291 Crore Board Declares Rs 25 Interim Dividend Uber Stock Dips Following 116 Billion Bid for Delivery Hero Analysts See Strategic Rationale US April Payrolls Surge Past Expectations but Underlying Weakness Raises Concerns BitMine Acquires 60000 Ethereum Amidst Extended Market Downturn Jobless Claims Drop to Lowest Level Since MidMay Reinforcing Labor Market Strength STRW Q1 2026 Earnings Earnings Beat Expectations Amidst Modest Stock Decline WAVE Q1 2026 Earnings EPS Surprises to the Upside Amid Limited Revenue Visibility TTGT Q1 2026 Earnings Significant EPS Miss Amidst Challenging Transition MNR Q1 2026 Earnings Significant EPS Miss Amid Challenging Environment ONBPO Q1 2026 Earnings Preferred Stock Reports EPS of 061 Narrowly Misses Estimates Haymaker Acquisition Corp 4 HYAC Q4 2025 Earnings Significant EPS Surprise Driven by Trust Interest Income Establishment Labs ESTA Posts Modest Gain as Shares Hold Above Key Support TransUnion TRU Gains Ground as Shares Approach Resistance CNH Industrial CNH Slightly Lower at 1011 as Support Levels Come into Focus Qiagen QGEN Edges Higher A Cautious Breakout from Consolidation RILYT Notes Slide 147 as Interest Rate Sensitivity Weighs on Bond Prices HCKT Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally Essential Properties Realty Trust Q1 2026 Earnings EPS Misses Estimates as Net Income Declines ELVA Q1 2026 Earnings EPS Surprises to the Upside Stock Rises Over 7 AMPY Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges RERE Q1 2026 Earnings EPS Crushes Estimates by Over 700 on Operational Strength INMB Q4 2025 Earnings EPS Beat Surprises as ClinicalStage Biotech Advances Pipeline